{"DataElement":{"publicId":"7656779","version":"1","preferredName":"Mutant Cellular Tumor Antigen p53 Immunohistochemistry Staining Method Positive Finding Cell Count","preferredDefinition":"Numeric value to represent the total count of epithelial cells expressing mutant p53 protein detected via immunohistochemical staining in biopsy samples.","longName":"MUT_P53_ICH_POS_CELL_COUNT","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"7656778","version":"1","preferredName":"Mutant Cellular Tumor Antigen p53 Immunohistochemistry Staining Method Positive Finding","preferredDefinition":"An altered form of an individual, organism, population, or genetic character that differs from the corresponding wild type due to one or more alterations (mutations)._Cellular tumor antigen p53 (393 aa, ~44 kDa) is encoded by the human TP53 gene. This protein plays a role in the regulation of both the cell cycle and apoptosis._Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen._A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","longName":"7656775v1.0:7656776v1.0","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"7656775","version":"1","preferredName":"Mutant Cellular Tumor Antigen p53","preferredDefinition":"An altered form of an individual, organism, population, or genetic character that differs from the corresponding wild type due to one or more alterations (mutations).:Cellular tumor antigen p53 (393 aa, ~44 kDa) is encoded by the human TP53 gene. This protein plays a role in the regulation of both the cell cycle and apoptosis.","longName":"C25360:C17387","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mutant","conceptCode":"C25360","definition":"An altered form of an individual, organism, population, or genetic character that differs from the corresponding wild type due to one or more alterations (mutations).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cellular Tumor Antigen p53","conceptCode":"C17387","definition":"Cellular tumor antigen p53 (393 aa, ~44 kDa) is encoded by the human TP53 gene. This protein plays a role in the regulation of both the cell cycle and apoptosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C22C5288-E2C7-38A5-E053-4EBD850A3C8F","latestVersionIndicator":"Yes","beginDate":"2021-05-12","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-12","modifiedBy":"ONEDATA","dateModified":"2021-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7656776","version":"1","preferredName":"Immunohistochemistry Staining Method Positive Finding","preferredDefinition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.:A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","longName":"C23020:C38758","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunohistochemistry Staining Method","conceptCode":"C23020","definition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C22C5288-E2D8-38A5-E053-4EBD850A3C8F","latestVersionIndicator":"Yes","beginDate":"2021-05-12","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-12","modifiedBy":"ONEDATA","dateModified":"2021-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C22C5288-E2E9-38A5-E053-4EBD850A3C8F","latestVersionIndicator":"Yes","beginDate":"2021-05-12","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-12","modifiedBy":"TITARENKOI","dateModified":"2021-05-21","changeDescription":"05/12/2021 created for SVAR NWU20-02-02_ti","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2531904","version":"1","preferredName":"Cell Count","preferredDefinition":"the cell count.","longName":"CELL_CT","context":"NHLBI","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":"1","maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2261845","version":"1","preferredName":"Count","preferredDefinition":"To determine the number or amount of something; the result of this activity.","longName":"C25463","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Count","conceptCode":"C25463","definition":"Determining the number or amount of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"FBB87F7A-646B-1AFC-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-13","modifiedBy":"ONEDATA","dateModified":"2005-07-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2093B339-B806-414E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-10-24","modifiedBy":"REEVESD","dateModified":"2009-11-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"p53 IHC","type":"Preferred Question Text","description":"p53 IHC","url":null,"context":"DCP"}],"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C22BC081-B6CC-6675-E053-4EBD850A1264","latestVersionIndicator":"Yes","beginDate":"2021-05-12","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-12","modifiedBy":"TITARENKOI","dateModified":"2021-05-21","changeDescription":"05/12/2021 created for SVAR NWU20-02-02_ti","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}